Remicade Psoriasis Approval Marks Debut Of Centocor Dermatology Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J subsidiary also anticipates eventually using the sales force for another psoriasis product it has in its pipeline.
You may also be interested in...
Remicade Ulcerative Colitis Indication Expands To Maintenance Therapy
Remicade becomes the only biologic indicated for inducing and maintaining clinical remission of ulcerative colitis and Crohn’s disease, according to Centocor.
Remicade Ulcerative Colitis Indication Expands To Maintenance Therapy
Remicade becomes the only biologic indicated for inducing and maintaining clinical remission of ulcerative colitis and Crohn’s disease, according to Centocor.
Abbott To Seek Humira Psoriasis Indication In 2007
The three-arm Phase III trial “exceeded” Abbott’s expectations and indicates Humira is first biologic treatment “to demonstrate superiority over methotrexate,” company says.